Close Menu

NEW YORK (360Dx) – New York City-based startup Paige.AI is using clinical-grade computation to evaluate the de-identified images of digitized slides and develop advanced technology for pathologists.

Leveraging artificial intelligence and deep learning software running on a supercomputer, the system is being developed to analyze and learn from large-scale datasets and then recognize types of cancer cells on slide images, separating them from healthy cells.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.